| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/10/2008 | CN101259275A Yolk antibody feed additive and injection for resisting sheep virosis and preparation thereof |
| 09/10/2008 | CN101259274A Yolk antibody feed additive and injection for resisting canine distemper and preparation thereof |
| 09/10/2008 | CN101259273A Yolk antibody feed additive and injection for resisting canine distemper and canine parvovirus disease and preparation thereof |
| 09/10/2008 | CN101259272A Yolk antibody feed additive and injection for resisting porcine reproductive and respiratory syndrome and preparation thereof |
| 09/10/2008 | CN101259271A Anti-diarrhea yolk antibody feed additive and injection for goat and preparation thereof |
| 09/10/2008 | CN101259270A Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies |
| 09/10/2008 | CN100417414C Methods for treating cancer using an immunotoxin |
| 09/09/2008 | US7423135 Expression vector comprising rodent regulatory sequences for use as gene expression control tools in genetic engineering |
| 09/09/2008 | US7423134 Protein AMSH and cDNA thereof |
| 09/09/2008 | US7423130 A nucleic acid sequence encoding the polypeptide, lacking its associated signal peptide |
| 09/09/2008 | US7423129 Antibodies to human eotaxin |
| 09/09/2008 | US7423128 To reduce inflammation and other disorders that are mediated, at least in part, by the alternative complement pathway |
| 09/09/2008 | US7423127 For diagnosis and therapy |
| 09/09/2008 | US7423126 Antibody that reacts with 6-sulfated sialyl Lewis X |
| 09/09/2008 | US7423125 Antibodies to VEGF-C |
| 09/09/2008 | US7423122 N-terminal and C-terminal markers in nascent proteins |
| 09/09/2008 | US7423118 IAPS associated cell cycle proteins, compositions and methods of use |
| 09/09/2008 | US7423115 Inducing an apoptosis or a killing of a cell, enhancing an effectiveness of cancer chemotherapy |
| 09/09/2008 | US7423114 GD2 ligands |
| 09/09/2008 | US7423023 Enhancement of immune response using targeting molecules |
| 09/09/2008 | US7423016 Genetic engineering; inducting immunology response |
| 09/09/2008 | US7422898 Nucleic acid encoding monkey Gpr103 |
| 09/09/2008 | US7422886 Human Phosphoinositide I3 Kinase p110 Delta which interacts with p85, has a broad phosphinositide specificity and is sensitive to the same kinase inhibitors as PI3 Kinase p110A; selectively expressed in leucocytes; enhanced expression in most melanomas |
| 09/09/2008 | US7422849 Hybridizing sample with a nucleic acid molecule to a transcript of gene wherein said transcript is RNA or cDNA; determining hybridization as a determination of expression of gene |
| 09/09/2008 | US7422846 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 09/09/2008 | US7422755 Vaccine against Haemophilus influenzae type a, Haemophilus influenzae type b, Staphylococcus aureus, and Staphylococcus epidermidis; glycoconjugate of cell wall polysaccharide from Bacillus pumilus Sh 18 |
| 09/09/2008 | US7422754 Neisseria meningitidis (Nm) polynucleotides and polypeptides; diagnostic. prophylactic and therapeutic uses |
| 09/09/2008 | US7422749 Isolated polypeptide, encoded by nucleic acid sequence, a vector from Staphylococcus; use for activators or inhibitors in therapy, antigen for vaccination, antibodies; antibacterial agent treating Staphylococcus infections; biodrugs |
| 09/09/2008 | US7422745 Methods of treating cancer with vαβ3-specific antibodies |
| 09/09/2008 | US7422744 Integrin mediated diseases like angiogenesis or restenosis; Vitaxin (a humanized monoclonal) antibody and a LM609 grafted antibody exhibiting selective binding affinity to alpha v beta 3 |
| 09/09/2008 | US7422743 Using DCRS5 (SEQ ID NOs: 1 or 2) or p19 (SEQ ID NOs: 5 or 6) cytokine receptors agonist or antagonist to treat rheumatoid arthritis, asthma, allergies, chronic obstructive pulmonary disorder, interstitial lung disorder, inflammatory bowel disorder, inflammatory skin disorder |
| 09/09/2008 | US7422742 Gene therapy using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders, administering antibody or antigen-binding fragment thereof that specifically binds IL-5 |
| 09/09/2008 | US7422741 VEGFR-3 fusion proteins |
| 09/09/2008 | US7422739 Anti-CD20 antibodies |
| 09/09/2008 | US7422738 Combined cancer treatment methods using antibodies to aminophospholipids |
| 09/09/2008 | CA2419696C Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes |
| 09/04/2008 | WO2008106134A2 Engineered anti-il-23r antibodies |
| 09/04/2008 | WO2008106116A2 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases |
| 09/04/2008 | WO2008105886A2 HUMANIZED FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF |
| 09/04/2008 | WO2008105740A1 A new immunoglobulin against helicobacter pylori |
| 09/04/2008 | WO2008105560A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
| 09/04/2008 | WO2008105462A1 Method for activation of helper t cell and composition for use in the method |
| 09/04/2008 | WO2008104808A2 Compounds and methods for the modulation of beta-1 integrin function to mediate tissue repair |
| 09/04/2008 | WO2008104805A2 Proteins |
| 09/04/2008 | WO2008104606A1 Method for antibody production |
| 09/04/2008 | WO2008104385A1 Method for the treatment of amyloidoses |
| 09/04/2008 | WO2008104321A1 Method for the selective determination of procalcitonin 1-116 for diagnostic purposes and antibodies and kits for carrying out such a method |
| 09/04/2008 | WO2008104194A1 Oxidized ldl and antibodies thereto for the treatment of atheroscleroti c plaques |
| 09/04/2008 | WO2008104184A2 Method for cloning cognate antibodies |
| 09/04/2008 | WO2008104183A2 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 09/04/2008 | WO2008091954A3 Optimized cd40 antibodies and methods of using the same |
| 09/04/2008 | WO2008073634A3 Compositions and methods for detecting and treating endothelial dysfunction |
| 09/04/2008 | WO2008055206A3 Humanized anti-factor d antibodies |
| 09/04/2008 | WO2008048670A3 Compositions and methods for modulating tlr14 activity |
| 09/04/2008 | WO2008013935A3 Tyrosine phosphorylation sites |
| 09/04/2008 | WO2007137275A3 Stimulators of osteoblastogenesis and applications of the same |
| 09/04/2008 | WO2007130962A3 Diagnosis of cardiovascular disease |
| 09/04/2008 | WO2007082379A8 Method to identify cd40-sensitive cells using gene expression |
| 09/04/2008 | WO2006047535A3 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 09/04/2008 | US20080216197 Pyridoxine biosynthetic protein for use in identifying agents which suppess growth of plants |
| 09/04/2008 | US20080214791 Human melanoma specific monoclonal antibody for use in diagnosis and treatment of cell proliferative disorders of the skin; tissue targeted therapy |
| 09/04/2008 | US20080214790 Leafthopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 09/04/2008 | US20080214789 Using tumor necrosis factor antagonist as therapeutic agent in treatment of rheumatoid arthritis |
| 09/04/2008 | US20080214788 Interferon-like protein zcyto21 |
| 09/04/2008 | US20080214787 MN Gene and Protein |
| 09/04/2008 | US20080214785 Heterodimeric receptor complex which antagonizes IL-10-related T cell-derived inducible factor for use in diagnosis, treatment and prevention of spleen associated cell proliferative disorders |
| 09/04/2008 | US20080214784 Human t1r2 taste receptor polypeptides |
| 09/04/2008 | US20080214782 Amino acid sequence phosphorylation site motif; structural variance and disease diagnosis |
| 09/04/2008 | US20080214487 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 09/04/2008 | US20080214453 Administering soluble receptor for advanced glycation endproduct (sRAGE) |
| 09/04/2008 | US20080214411 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 09/04/2008 | US20080214406 Look-Through Mutagenesis For Developing Altered Polypeptides With Enhanced Properties |
| 09/04/2008 | US20080213918 Polynucleotides encoding two novel human G-protein coupled receptors, HGPRBMY28 and HGPRBMY29, and splice variants thereof |
| 09/04/2008 | US20080213917 Hydroxy-isophthalamide moieties; antibodies; high stability, luminescence; kits |
| 09/04/2008 | US20080213907 Protein markers for the diagnosis and prognosis of ovarian and breast cancer |
| 09/04/2008 | US20080213893 Isolation of neural stem cells using gangliosides and other surface markers |
| 09/04/2008 | US20080213890 Antibody-avidin fusion proteins as cytotoxic drugs |
| 09/04/2008 | US20080213880 Chimeric t1r1 taste receptor encoding nucleic acid sequences and vectors |
| 09/04/2008 | US20080213878 Novel human membrane proteins and polynucleotides encoding the same |
| 09/04/2008 | US20080213852 Nucleotide sequences coding sugar transporter and/or sugar alcohol transporter for use in enhanced fermentation of vitamin c |
| 09/04/2008 | US20080213837 Apo-3 ligand polypeptide |
| 09/04/2008 | US20080213834 Gsk3 ligands and polynucleotides encoding gsk3 ligands |
| 09/04/2008 | US20080213833 Methods for Obtaining Optically Active Glycidyl Ethers and Optically Active Vicinal Diols from Racemic Substrates |
| 09/04/2008 | US20080213831 Human cytokine receptor |
| 09/04/2008 | US20080213822 Methods for diagnosing celiac sprue and reagents useful therein |
| 09/04/2008 | US20080213816 Mitochondrial enoyl coenzyme a hydratase 1 as marker for diagnosing stomach cancer |
| 09/04/2008 | US20080213806 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
| 09/04/2008 | US20080213795 Plasmodium epitope polypeptide for use in treatment and prevention malarial infection |
| 09/04/2008 | US20080213793 Antibodies that bind receptor protein designated 2f1 |
| 09/04/2008 | US20080213786 Using lectin modulators as treatments for cell proliferative and inflammatory disorders |
| 09/04/2008 | US20080213779 Using variation in NLR family, pyrin domain containing 7 (NALP7) gene as evaluative tool in diagnosis/prognosis of gestation disorders |
| 09/04/2008 | US20080213778 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/04/2008 | US20080213759 Novel Angiogenesis Inhibitor |
| 09/04/2008 | US20080213426 Producing food products from a transgenic non-human animal with increased number of ribs; treating obesity, spinal cord injury, kidney, nervous system and muscular diseases; antisense agents |
| 09/04/2008 | US20080213314 Combined dna vaccine and biological modifiers for cancer therapy |
| 09/04/2008 | US20080213310 Use of lytic toxins and toxin conjugates |
| 09/04/2008 | US20080213296 Ligand bound viral envelope protein for use in inducing anti-human immunodeficiency virus antibodies; treatment and prevention of viral disease |
| 09/04/2008 | US20080213294 Immunization of dairy cattle with GapC protein against streptococcus infection |
| 09/04/2008 | US20080213287 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 09/04/2008 | US20080213286 Composition comprising mastermind domain (MAM) polypeptide for use in treatment of cardiovascular and cell proliferative disorders |